The Enterprise Value as of December 2025 (TTM) for InnoPharmax Inc. (4172.TWO) is 2.10B

According to InnoPharmax Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.10B. This represents a change of 33.10% compared to the average of 1.57B of the last 4 quarters.

InnoPharmax Inc. (4172.TWO) Historical Enterprise Value (quarterly & annually)

How has 4172.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of InnoPharmax Inc. over the last ten years is 1.22B. The current 2.10B Enterprise Value has changed 17.12% with respect to the historical average. Over the past ten years (40 quarters), 4172.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 2.55B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

InnoPharmax Inc. (4172.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of InnoPharmax Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InnoPharmax Inc. (4172.TWO) Average Enterprise Value

How has 4172.TWO Enterprise Value performed in the past?

The current Enterprise Value of InnoPharmax Inc. (4172.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

InnoPharmax Inc. (4172.TWO) Enterprise Value vs. Peers

How is 4172.TWO’s Enterprise Value compared to its peers?

InnoPharmax Inc.’s Enterprise Value is greater than Winston Medical Supply Co., Ltd. (1.40B), greater than LIWANLI Innovation Co., Ltd. (1.71B), greater than TSH Biopharm Corporation Limited (1.62B), less than Golden Biotechnology Corporation (5.82B), less than Allied Biotech Corporation (2.28B), less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.56B), greater than GeneFerm Biotechnology Co., Ltd. (2.04B), greater than Advagene Biopharma Co., Ltd. (1.73B), greater than Shangya Technology Co., Ltd. (2.02B), less than Sunny Pharmtech Inc. (2.46B),

Build a custom stock screener for InnoPharmax Inc. (4172.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoPharmax Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InnoPharmax Inc. (4172.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InnoPharmax Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.